{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:05:55Z","timestamp":1732043155900},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,27]]},"DOI":"10.7759\/cureus.49532","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T07:01:02Z","timestamp":1701154862000},"source":"Crossref","is-referenced-by-count":2,"title":["Atorvastatin as an Antihypertensive Agent: A Pilot Study"],"prefix":"10.7759","author":[{"given":"Niaz","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Faheem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himayat","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosam","family":"Shabana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arafat","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud O","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Essam","family":"Elmahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Hypertension. (2023). Accessed. 06\/02\/2023: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.023163","article-title":"Modifiable risk factors and atrial fibrillation","volume":"136","author":"Lau DH","year":"2017","unstructured":"Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable risk factors and atrial fibrillation. Circulation. 2017, 136:583-96. 10.1161\/CIRCULATIONAHA.116.023163","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1333599","article-title":"Treatment options and considerations for hypertensive patients to prevent dementia","volume":"18","author":"Hernandorena I","year":"2017","unstructured":"Hernandorena I, Duron E, Vidal JS, Hanon O. Treatment options and considerations for hypertensive patients to prevent dementia. Expert Opin Pharmacother. 2017, 18:989-1000. 10.1080\/14656566.2017.1333599","journal-title":"Expert Opin Pharmacother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2015.01.009","article-title":"Global burden of cardiovascular disease and stroke: hypertension at the core","volume":"31","author":"Lackland DT","year":"2015","unstructured":"Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015, 31:569-71. 10.1016\/j.cjca.2015.01.009","journal-title":"Can J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5543\/tkda.2023.74249","article-title":"Predictive value of the SCORE, SCORE2, and pooled cohort risk equation systems in patients with hypertension","volume":"51","author":"Karakayal\u0131 M","year":"2023","unstructured":"Karakayal\u0131 M, P\u00fc\u015f\u00fcro\u011flu H, Altunova M, Y\u0131lmaz E, G\u00fcll\u00fc A. Predictive value of the SCORE, SCORE2, and pooled cohort risk equation systems in patients with hypertension. Turk Kardiyol Dern Ars. 2023, 51:407-14. 10.5543\/tkda.2023.74249","journal-title":"Turk Kardiyol Dern Ars"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32225-6","article-title":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","unstructured":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017. a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018, 392:1923-94. 10.1016\/S0140-6736(18)32225-6","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001683","article-title":"Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV","volume":"18","author":"Williams B","year":"2004","unstructured":"Williams B, Poulter NR, Brown MJ, et al.. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004, 18:139-85. 10.1038\/sj.jhh.1001683","journal-title":"J Hum Hypertens"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian AV","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al.. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003, 42:1206-52. 10.1161\/01.HYP.0000107251.49515.c2","journal-title":"Hypertension"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f0580f","article-title":"2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension","volume":"25","author":"Mancia G","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, et al.. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens. 2007, 25:1751-62. 10.1097\/HJH.0b013e3282f0580f","journal-title":"J Hypertens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.189010","article-title":"Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association","volume":"52","author":"Pickering TG","year":"2008","unstructured":"Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008, 52:10-29. 10.1161\/HYPERTENSIONAHA.107.189010","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328363e964","article-title":"European Society of Hypertension position paper on ambulatory blood pressure monitoring","volume":"31","author":"O'Brien E","year":"2013","unstructured":"O'Brien E, Parati G, Stergiou G, et al.. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013, 31:1731-68. 10.1097\/HJH.0b013e328363e964","journal-title":"J Hypertens"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.10.069","article-title":"Blood pressure assessment in adults in clinical practice and clinic-based research: JACC scientific expert panel","volume":"73","author":"Muntner P","year":"2019","unstructured":"Muntner P, Einhorn PT, Cushman WC, et al.. Blood pressure assessment in adults in clinical practice and clinic-based research: JACC scientific expert panel. J Am Coll Cardiol. 2019, 73:317-35. 10.1016\/j.jacc.2018.10.069","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12081","article-title":"Antihypertensive effects of statins: a meta-analysis of prospective controlled studies","volume":"15","author":"Briasoulis A","year":"2013","unstructured":"Briasoulis A, Agarwal V, Valachis A, Messerli FH. Antihypertensive effects of statins: a meta-analysis of prospective controlled studies. J Clin Hypertens (Greenwich). 2013, 15:310-20. 10.1111\/jch.12081","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1002001","article-title":"Statins: another class of antihypertensive agents?","volume":"20","author":"Milionis HJ","year":"2006","unstructured":"Milionis HJ, Liberopoulos EN, Achimastos A, Elisaf MS, Mikhailidis DP. Statins: another class of antihypertensive agents?. J Hum Hypertens. 2006, 20:320-35. 10.1038\/sj.jhh.1002001","journal-title":"J Hum Hypertens"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1097\/00041433-199202000-00005","article-title":"HMG CoA reductase inhibitors","volume":"3","author":"Hunninghake DB","year":"1992","unstructured":"Hunninghake DB. HMG CoA reductase inhibitors. Curr Opin Lipidol. 1992, 3:22-8.","journal-title":"Curr Opin Lipidol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2009.05.019","article-title":"Calcium channel regulation in vascular smooth muscle cells: synergistic effects of statins and calcium channel blockers","volume":"139","author":"Clunn GF","year":"2010","unstructured":"Clunn GF, Sever PS, Hughes AD. Calcium channel regulation in vascular smooth muscle cells: synergistic effects of statins and calcium channel blockers. Int J Cardiol. 2010, 139:2-6. 10.1016\/j.ijcard.2009.05.019","journal-title":"Int J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-007-1008-7","article-title":"Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia","volume":"23","author":"Ge CJ","year":"2008","unstructured":"Ge CJ, Lu SZ, Chen YD, Wu XF, Hu SJ, Ji Y. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. Heart Vessels. 2008, 23:91-5. 10.1007\/s00380-007-1008-7","journal-title":"Heart Vessels"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-016-0086-5","article-title":"Current statins show calcium channel blocking activity through voltage gated channels","volume":"17","author":"Ali N","year":"2016","unstructured":"Ali N, Begum R, Faisal MS, et al.. Current statins show calcium channel blocking activity through voltage gated channels. BMC Pharmacol Toxicol. 2016, 17:43. 10.1186\/s40360-016-0086-5","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000952","article-title":"Prevalence and incidence of hypertension in the general adult population: results of the CARLA-cohort study","volume":"94","author":"Lacruz ME","year":"2015","unstructured":"Lacruz ME, Kluttig A, Hartwig S, et al.. Prevalence and incidence of hypertension in the general adult population: results of the CARLA-cohort study. Medicine (Baltimore). 2015, 94:e952. 10.1097\/MD.0000000000000952","journal-title":"Medicine (Baltimore)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.02.003","article-title":"Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study","volume":"148","author":"Borghi C","year":"2004","unstructured":"Borghi C, Dormi A, Veronesi M, Sangiorgi Z, Gaddi A. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J. 2004, 148:285-92. 10.1016\/j.ahj.2004.02.003","journal-title":"Am Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200004000-00006","article-title":"Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia","volume":"35","author":"Borghi C","year":"2000","unstructured":"Borghi C, Prandin MG, Costa FV, Bacchelli S, Degli Esposti D, Ambrosioni E. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol. 2000, 35:549-55. 10.1097\/00005344-200004000-00006","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.06.006","article-title":"Are statins effective for simultaneously treating dyslipidemias and hypertension?","volume":"196","author":"Koh KK","year":"2008","unstructured":"Koh KK, Quon MJ, Waclawiw MA. Are statins effective for simultaneously treating dyslipidemias and hypertension?. Atherosclerosis. 2008, 196:1-8. 10.1016\/j.atherosclerosis.2007.06.006","journal-title":"Atherosclerosis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2005.04533.x","article-title":"Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine\/atorvastatin gemini study)","volume":"7","author":"Blank R","year":"2005","unstructured":"Blank R, LaSalle J, Reeves R, Maroni J, Tarasenko L, Sun F. Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine\/atorvastatin gemini study). J Clin Hypertens (Greenwich). 2005, 7:264-73. 10.1111\/j.1524-6175.2005.04533.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl403","article-title":"Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial","volume":"27","author":"Sever P","year":"2006","unstructured":"Sever P, Dahl\u00f6f B, Poulter N, et al.. Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J. 2006, 27:2982-8. 10.1093\/eurheartj\/ehl403","journal-title":"Eur Heart J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2006.05636.x","article-title":"Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial","volume":"8","author":"Messerli FH","year":"2006","unstructured":"Messerli FH, Bakris GL, Ferrera D, et al.. Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial. J Clin Hypertens (Greenwich). 2006, 8:571-81; quiz 582-3. 10.1111\/j.1524-6175.2006.05636.x","journal-title":"J Clin Hypertens (Greenwich)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/204672-atorvastatin-as-an-antihypertensive-agent-a-pilot-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:36Z","timestamp":1707509256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/204672-atorvastatin-as-an-antihypertensive-agent-a-pilot-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.49532","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,27]]}}}